206 related articles for article (PubMed ID: 34125976)
1. Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.
Izak M; Gendelman V; Bransburg-Zabary S; Stoyanov E; Gat R; Cohen D; Chen J; Maor Y; Benov A; Lev B; Zimhony O; Shinar E
Vox Sang; 2022 Feb; 117(2):185-192. PubMed ID: 34125976
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
[TBL] [Abstract][Full Text] [Related]
3. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations.
Hayes C; Rubenstein W; Gibb D; Klapper E; Tanaka J; Pepkowitz S
Transfusion; 2021 Aug; 61(8):2245-2249. PubMed ID: 34036595
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation.
Schmidt AE; Vogel P; Chastain CA; Barnes T; Roth NJ; Simon TL
J Clin Apher; 2022 Oct; 37(5):449-459. PubMed ID: 35815776
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area.
Jain S; Garg K; Tran SM; Rask IL; Tarczon M; Nandi V; Kessler DA; Strauss D; Sachais BS; Yazdanbakhsh K; Rehmani S; Luchsinger L; Shi PA
Transfusion; 2021 Aug; 61(8):2374-2383. PubMed ID: 33904609
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations.
Karbiener M; Farcet MR; Ilk R; Schreiner J; Lenart J; Powers N; Stewart JM; Tallman H; Kreil TR
Transfusion; 2021 Apr; 61(4):1141-1147. PubMed ID: 33615484
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors.
Lasky B; Goodhue Meyer E; Steele WR; Crowder LA; Young PP
Transfusion; 2021 May; 61(5):1471-1478. PubMed ID: 33458811
[TBL] [Abstract][Full Text] [Related]
8. Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
Balcerek J; Trejo E; Levine K; Couey P; Kornberg ZV; Rogine C; Young C; Li PJ; Shy BR; Taylor JE; Bakhtary S; Friedlander T; Lynch KL; Bern C; Esensten JH
Am J Clin Pathol; 2021 Mar; 155(4):515-521. PubMed ID: 33399201
[TBL] [Abstract][Full Text] [Related]
9. [COVID-19 - BLOOD GROUPS, ANTIBODIES AND CONVALESCENT PLASMA].
Izak M; Yahalom V; Maor Y; Zimhoni O; Cohen D; Chen J; Shinar E
Harefuah; 2021 Mar; 160(3):139-143. PubMed ID: 33749174
[TBL] [Abstract][Full Text] [Related]
10. Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors.
Grujić J; Bujandrić N; Budakov-Obradović Z; Dolinaj V; Bogdan D; Savić N; Cabezas-Cruz A; Mijatović D; Simin V; Anđelić N; Banović P
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010301
[TBL] [Abstract][Full Text] [Related]
11. The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection.
Fazeli A; Sharifi S; Mohammadi S; Bahraini M; Arabkhazaeli A; Jelveh N; Eshghi P
Transfus Apher Sci; 2022 Apr; 61(2):103302. PubMed ID: 34774440
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors.
Leon J; Merrill AE; Rogers K; Kurt J; Dempewolf S; Ehlers A; Jackson JB; Knudson CM
Transfus Apher Sci; 2022 Apr; 61(2):103326. PubMed ID: 34862140
[TBL] [Abstract][Full Text] [Related]
13. Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.
Körper S; Jahrsdörfer B; Corman VM; Pilch J; Wuchter P; Blasczyk R; Müller R; Tonn T; Bakchoul T; Schäfer R; Juhl D; Schwarz T; Gödecke N; Burkhardt T; Schmidt M; Appl T; Eichler H; Klüter H; Drosten C; Seifried E; Schrezenmeier H
Transfus Med Hemother; 2021 May; 48(3):137-147. PubMed ID: 34177417
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.
Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR
Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India.
Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S
Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953
[TBL] [Abstract][Full Text] [Related]
16. Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience.
Reik R; Gammon RR; Carol N; Smith J; Grable M; Forbes S; Wu Y; Reed L; Rogers M; Prichard A; Paul S; Scholl G
J Clin Apher; 2021 Aug; 36(4):533-546. PubMed ID: 33648025
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections.
Wendel S; Fontão-Wendel R; Fachini R; Candelaria G; Scuracchio P; Achkar R; Brito M; Reis LF; Camargo A; Amano M; Machado R; Araujo D; Soares C; Durigon E
Transfusion; 2021 May; 61(5):1447-1460. PubMed ID: 33604884
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 convalescent plasma: Evolving strategies for serological screening in France.
Gallian P; Le Cam S; Brisbarre N; Pastorino B; Amroun A; Malard L; de Lamballerie X; Bliem C; Richard P; Morel P; Tiberghien P
Vox Sang; 2022 Apr; 117(4):606-610. PubMed ID: 34897745
[TBL] [Abstract][Full Text] [Related]
20. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
